Can liquid biopsy-guided EGFR-targeted therapy be a surrogate for the tissue-based standard approach?

被引:0
作者
Oh, In-Jae [1 ,2 ]
机构
[1] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
关键词
CIRCULATING TUMOR DNA; FACTOR RECEPTOR MUTATIONS; CELL LUNG-CANCER; PHASE-III; GEFITINIB; 1ST-LINE; PREDICTOR; ERLOTINIB;
D O I
10.21037/tlcr.2019.06.03
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S351 / S354
页数:4
相关论文
共 21 条
[11]   Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy [J].
Mok, Tony ;
Wu, Yi-Long ;
Lee, Jin Soo ;
Yu, Chong-Jen ;
Sriuranpong, Virote ;
Sandoval-Tan, Jennifer ;
Ladrera, Guia ;
Thongprasert, Sumitra ;
Srimuninnimit, Vichien ;
Liao, Meilin ;
Zhu, Yunzhong ;
Zhou, Caicun ;
Fuerte, Fatima ;
Margono, Benjamin ;
Wen, Wei ;
Tsai, Julie ;
Truman, Matt ;
Klughammer, Barbara ;
Shames, David S. ;
Wu, Lin .
CLINICAL CANCER RESEARCH, 2015, 21 (14) :3196-3203
[12]   Circulating tumor DNA analysis in patients with EGFR mutant lung cancer [J].
Nanjo, Shigeki ;
Bivona, Trever G. .
JOURNAL OF THORACIC DISEASE, 2018, 10 :S4061-S4064
[13]   ctDNA and CTCs in Liquid Biopsy - Current Status and Where We Need to Progress [J].
Neumann, Martin H. D. ;
Bender, Sebastian ;
Krahn, Thomas ;
Schlange, Thomas .
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2018, 16 :190-195
[14]   Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC [J].
Rolfo, Christian ;
Mack, Philip C. ;
Scagliotti, Giorgio V. ;
Baas, Paul ;
Barlesi, Fabrice ;
Bivona, Trever G. ;
Herbst, Roy S. ;
Mok, Tony S. ;
Peled, Nir ;
Pirker, Robert ;
Raez, Luis E. ;
Reck, Martin ;
Riess, Jonathan W. ;
Sequist, Lecia V. ;
Shepherd, Frances A. ;
Sholl, Lynette M. ;
Tan, Daniel S. W. ;
Wakelee, Heather A. ;
Wistuba, Ignacio I. ;
Wynes, Murry W. ;
Carbone, David P. ;
Hirsch, Fred R. ;
Gandara, David R. .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) :1248-1268
[15]   Circulating tumour DNA genomics in EGFR-mutant lung adenocarcinoma [J].
Rosell, Rafael ;
Karachaliou, Niki .
LANCET RESPIRATORY MEDICINE, 2018, 6 (09) :649-651
[16]   Epidermal growth factor receptor mutations in lung cancer [J].
Sharma, Sreenath V. ;
Bell, Daphne W. ;
Settleman, Jeffrey ;
Haber, Daniel A. .
NATURE REVIEWS CANCER, 2007, 7 (03) :169-181
[17]   Liquid biopsies come of age: towards implementation of circulating tumour DNA [J].
Wan, Jonathan C. M. ;
Massie, Charles ;
Garcia-Corbacho, Javier ;
Mouliere, Florent ;
Brenton, James D. ;
Caldas, Carlos ;
Pacey, Simon ;
Baird, Richard ;
Rosenfeld, Nitzan .
NATURE REVIEWS CANCER, 2017, 17 (04) :223-238
[18]   Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial [J].
Wang, Zhijie ;
Cheng, Ying ;
An, Tongtong ;
Gao, Hongjun ;
Wang, Kai ;
Zhou, Qing ;
Hu, Yanping ;
Song, Yong ;
Ding, Cuimin ;
Peng, Feng ;
Liang, Li ;
Hu, Yi ;
Huang, Cheng ;
Zhou, Caicun ;
Shi, Yuankai ;
Zhang, Li ;
Ye, Xin ;
Zhang, Meizhuo ;
Chuai, Shaokun ;
Zhu, Guanshan ;
Hu, Jin ;
Wu, Yi-long ;
Wang, Jie .
LANCET RESPIRATORY MEDICINE, 2018, 6 (09) :681-690
[19]   Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JS']JSMO, KSMO, MOS, SSO and TOS [J].
Wu, Y. -L. ;
Planchard, D. ;
Lu, S. ;
Sun, H. ;
Yamamoto, N. ;
Kim, D. -W. ;
Tan, D. S. W. ;
Yang, J. C. -H. ;
Azrif, M. ;
Mitsudomi, T. ;
Park, K. ;
Soo, R. A. ;
Chang, J. W. C. ;
Alip, A. ;
Peters, S. ;
Douillard, J. -Y. .
ANNALS OF ONCOLOGY, 2019, 30 (02) :171-210
[20]   Liquid biopsy guided precision therapy for lung cancers [J].
Xu, Chongrui ;
Offin, Michael ;
Paik, Paul K. ;
Li, Bob T. .
JOURNAL OF THORACIC DISEASE, 2018, 10 :S4173-S4175